With the idea that NOX4 contributes to RAGE-mediated ROS production in the progression of AD, its role in AD pathogenesis is being investigated, and it is thought to be a therapeutic target for the treatment of the disease [14,17,18,21]. Here, NOX4 is linked to Alzheimer disease.